Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tanshinone I inhibit normal and malignant hematopoiesis by repressing EZH2 activity [human]
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
Tanshinone I inhibit normal and malignant hematopoiesis by repressing EZH2 activity
PubMed Full text in PMC Similar studies
Tanshinone I inhibit normal and malignant hematopoiesis by repressing EZH2 activity [zebrafish]
PubMed Full text in PMC Similar studies SRA Run Selector
Transcriptome analysis for KDM6A mutated urothelial bladder carcinoma and EZH2 inhibitor treated KDM6A mutated urothelial bladder carcinoma
PubMed Similar studies Analyze with GEO2RSRA Run Selector
High-throughput deep sequence of zebrafish wild-type and ezh2 mutant embryos
The Polycomb Repressive Complex 2 Is Required For MLL-AF9 Leukemia
PubMed Full text in PMC Similar studies Analyze with GEO2R
Epigenetic profiling of WT and Ezh2-null MLL-AF9 murine leukemic cells
Expression profiling of secondary wild type (WT) and Ezh2-null murine MLL-AF9 AML
Expression profiling of primary wild type (WT), Ezh2-null and Eed-null murine MLL-AF9 AML
Epigenetic pattern after EZH1,2 inhibition in lymohoma cells
PubMed Similar studies
Expression analysis after EZH1,2 inhibition in lymohoma cells
PubMed Similar studies Analyze with GEO2R
Gene expression of extranodal NK/T cell lymphoma
Gene expression of extranodal NK/T cell lymphoma II
Gene expression of extranodal NK/T cell lymphoma I
Expression data from NKYS transfected with siRNAs or plasmids
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment
Genome-wide Profiling of H3K27ac binding in human cancer cell lines
PubMed Similar studies SRA Run Selector
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells
EZH2 is a potential therapeutic target for H3K27M mutant paediatric gliomas
EZH2 inhibition as a targeted therapy for H3K27M mutant pediatric gliomas [RNA-Seq]
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on